The Benefits and Backlash of PainKillers to Pharmaceutical Companies
On Sept. 15th, 2018, Purdue Pharma, maker of the prescription painkiller OxyContin, stated that it would file a bankruptcy petition to end those more than 2000 class actions. It has offered a settlement deal said to be worth as much as $12 billion maximum. It and the other pharmaceutical company Execs already in pay $634.5 million fine in which case. OxyContin tablets should be taken at 12-hourly intervals. Since the drug’s debut in 1995, the company has been confronted with additional evidence including complaints from doctors, reports from sales reps and independent research. The manufacturing companies concealed the dangers of such drug, they had no control over the problems of false commericals and mass sales which aroused over-prescription. They used to refocus and educate physicians to dispense those medicine. Then many doctors began prescribing OxyContin at shorter intervals in the late 1990s.